Central African Republic vs United Arab Emirates: Hypertension among adults aged 30-79 years, prevalence
Central African Republic
41.3
in 2019
United Arab Emirates
41.4
in 2019
Central African Republic rank
63rd
United Arab Emirates rank
62nd
Hypertension among adults aged 30-79 years, prevalence over time
- Central African Republic
- United Arab Emirates
How they compare
United Arab Emirates currently reports 41.4 against 41.3 in Central African Republic, a difference of 0.1.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Central African Republic ahead.
Central African Republic ranks 63rd and United Arab Emirates ranks 62nd of 193 countries.
Central African Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central African Republic | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 39.95 | 37.15 | 2.8 | Central African Republic |
| 2000s | 41.37 | 38.3 | 3.07 | Central African Republic |
| 2010s | 41.74 | 40.24 | 1.5 | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension among adults aged 30-79 years, prevalence, Central African Republic or United Arab Emirates?
- United Arab Emirates, at 41.4 against 41.3 in Central African Republic as of 2019.
- What is the difference in hypertension among adults aged 30-79 years, prevalence between Central African Republic and United Arab Emirates?
- 0.1, with United Arab Emirates ahead.
- How many years of comparable data are there for Central African Republic and United Arab Emirates?
- 30 years are reported by both, from 1990 to 2019.
- How do Central African Republic and United Arab Emirates rank globally for hypertension among adults aged 30-79 years, prevalence?
- Central African Republic ranks 63rd and United Arab Emirates ranks 62nd of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension among adults aged 30-79 years, prevalence, age-standardized. Statizoid refreshes it automatically from the source and publishes the full history for both places.